TY - BOOK AU - Neyt, M. AU - Christiaens, T. AU - Demotes, J. AU - Hulstaert, F. PY - 2015 DA - 2015// TI - Publicly funded practice-oriented clinical trials PB - Belgian Health Care Knowledge Centre (KCE) CY - Brussels ID - Neyt2015 ER - TY - JOUR AU - Viergever, R. F. AU - Hendriks, T. C. PY - 2016 DA - 2016// TI - The 10 largest public and philanthropic funders of health research in the world: what they fund and how they distribute their funds JO - Health Res Policy Syst VL - 14 UR - https://doi.org/10.1186/s12961-015-0074-z DO - 10.1186/s12961-015-0074-z ID - Viergever2016 ER - TY - JOUR AU - Bertolini, F. AU - Sukhatme, V. P. AU - Bouche, G. PY - 2015 DA - 2015// TI - Drug repurposing in oncology–patient and health systems opportunities JO - Nat Rev Clin Oncol VL - 12 UR - https://doi.org/10.1038/nrclinonc.2015.169 DO - 10.1038/nrclinonc.2015.169 ID - Bertolini2015 ER - TY - JOUR AU - Naci, H. AU - Ioannidis, J. P. PY - 2013 DA - 2013// TI - Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study JO - BMJ VL - 347 UR - https://doi.org/10.1136/bmj.f5577 DO - 10.1136/bmj.f5577 ID - Naci2013 ER - TY - JOUR AU - Williams, H. C. AU - Burden-Teh, E. AU - Nunn, A. J. PY - 2015 DA - 2015// TI - What is a pragmatic clinical trial? JO - J Invest Dermatol VL - 135 UR - https://doi.org/10.1038/jid.2015.134 DO - 10.1038/jid.2015.134 ID - Williams2015 ER - TY - JOUR AU - Anderson, M. L. AU - Califf, R. M. AU - Sugarman, J. PY - 2015 DA - 2015// TI - Ethical and regulatory issues of pragmatic cluster randomized trials in contemporary health systems JO - Clin Trials VL - 12 UR - https://doi.org/10.1177/1740774515571140 DO - 10.1177/1740774515571140 ID - Anderson2015 ER - TY - JOUR AU - Califf, R. M. AU - Sugarman, J. PY - 2015 DA - 2015// TI - Exploring the ethical and regulatory issues in pragmatic clinical trials JO - Clin Trials VL - 12 UR - https://doi.org/10.1177/1740774515598334 DO - 10.1177/1740774515598334 ID - Califf2015 ER - TY - JOUR AU - Pham, C. T. AU - Karnon, J. D. AU - Middleton, P. F. AU - Bloomfield, F. H. AU - Groom, K. M. AU - Crowther, C. A. PY - 2017 DA - 2017// TI - Randomised clinical trials in perinatal health care: a cost-effective investment JO - Med J Aust VL - 207 UR - https://doi.org/10.5694/mja16.01178 DO - 10.5694/mja16.01178 ID - Pham2017 ER - TY - JOUR AU - Schilsky, R. L. PY - 2013 DA - 2013// TI - Publicly funded clinical trials and the future of cancer care JO - Oncologist VL - 18 UR - https://doi.org/10.1634/theoncologist.2012-0423 DO - 10.1634/theoncologist.2012-0423 ID - Schilsky2013 ER - TY - JOUR AU - Mailankody, S. AU - Prasad, V. PY - 2014 DA - 2014// TI - Comparative effectiveness questions in oncology JO - N Engl J Med VL - 370 UR - https://doi.org/10.1056/NEJMp1400104 DO - 10.1056/NEJMp1400104 ID - Mailankody2014 ER - TY - JOUR AU - Perner, A. AU - Haase, N. AU - Guttormsen, A. B. AU - Tenhunen, J. AU - Klemenzson, G. AU - Aneman, A. PY - 2012 DA - 2012// TI - Hydroxyethyl starch 130/0.42 versus Ringer’s acetate in severe sepsis JO - N Engl J Med VL - 367 UR - https://doi.org/10.1056/NEJMoa1204242 DO - 10.1056/NEJMoa1204242 ID - Perner2012 ER - TY - JOUR AU - Unger, J. M. AU - LeBlanc, M. AU - Blanke, C. D. PY - 2017 DA - 2017// TI - The effect of positive SWOG treatment trials on survival of patients with cancer in the US population JO - JAMA Oncol VL - 3 UR - https://doi.org/10.1001/jamaoncol.2017.0762 DO - 10.1001/jamaoncol.2017.0762 ID - Unger2017 ER - TY - JOUR AU - Annemans, L. AU - Cleemput, I. AU - Hulstaert, F. AU - Simoens, S. PY - 2012 DA - 2012// TI - Comparative effectiveness research and measuring the level of pharmaceutical innovation in the EU JO - J Comp Eff Res VL - 1 UR - https://doi.org/10.2217/cer.11.1 DO - 10.2217/cer.11.1 ID - Annemans2012 ER - TY - JOUR AU - Walters, S. J. AU - Bonacho Dos Anjos Henriques-Cadby, I. AU - Bortolami, O. AU - Flight, L. AU - Hind, D. AU - Jacques, R. M. PY - 2017 DA - 2017// TI - Recruitment and retention of participants in randomised controlled trials: a review of trials funded and published by the United Kingdom Health Technology Assessment Programme JO - BMJ Open VL - 7 UR - https://doi.org/10.1136/bmjopen-2016-015276 DO - 10.1136/bmjopen-2016-015276 ID - Walters2017 ER - TY - STD TI - The Netherlands Organisation for Health Research and Development (ZonMw). Available from: https://www.zonmw.nl/en/. Cited 07/05/2019. UR - https://www.zonmw.nl/en/ ID - ref15 ER - TY - BOOK PY - 2018 DA - 2018// TI - The KCE Trials programme ID - ref16 ER - TY - STD TI - National Institue for Health Research (NIHR) in England. Faster costing and contracting. https://www.nihr.ac.uk/documents/the-excel-industry-costing-template-getting-started/12177. Accessed 2 Dec 2019. UR - https://www.nihr.ac.uk/documents/the-excel-industry-costing-template-getting-started/12177 ID - ref17 ER - TY - BOOK PY - 2015 DA - 2015// TI - Development of a table of standard costs for conducting clinical trials in Australia 2015 ID - ref18 ER - TY - JOUR AU - Asselt, T. AU - Ramaekers, B. AU - Corro Ramos, I. AU - Joore, M. AU - Al, M. AU - Lesman-Leegte, I. PY - 2018 DA - 2018// TI - Research costs investigated: a study into the budgets of Dutch publicly funded drug-related research JO - Pharmacoeconomics VL - 36 UR - https://doi.org/10.1007/s40273-017-0572-7 DO - 10.1007/s40273-017-0572-7 ID - Asselt2018 ER - TY - STD TI - Büro für Technikfolgen-Abschätzung beim Deutschen Bundestag (TAB). Stand und Bedingungen klinischer Forschung in Deutschland und im Vergleich zu anderen Ländern unter besondere Berücksichtigung nichtkommerzieller Studien. Innovationsreport. Arbeitsbericht nr. 135; 2010. ID - ref20 ER - TY - JOUR AU - Djurisic, S. AU - Rath, A. AU - Gaber, S. AU - Garattini, S. AU - Bertele, V. AU - Ngwabyt, S. N. PY - 2017 DA - 2017// TI - Barriers to the conduct of randomised clinical trials within all disease areas JO - Trials VL - 18 UR - https://doi.org/10.1186/s13063-017-2099-9 DO - 10.1186/s13063-017-2099-9 ID - Djurisic2017 ER - TY - STD TI - Oldgren J. Prospective registry-based randomized clinical trials – the Swedish concept for pragmatic clinical trials. In: Slides presented at KCE Trials symposium, Brussels; 2017. https://kce.fgov.be/sites/default/files/atoms/files/Jonas_Oldgren_RRCT%2028Nov2017.pdf. Accessed 2 Dec 2019. UR - https://kce.fgov.be/sites/default/files/atoms/files/Jonas_Oldgren_RRCT%2028Nov2017.pdf ID - ref22 ER - TY - JOUR AU - Cowie, M. R. AU - Blomster, J. I. AU - Curtis, L. H. AU - Duclaux, S. AU - Ford, I. AU - Fritz, F. PY - 2017 DA - 2017// TI - Electronic health records to facilitate clinical research JO - Clin Res Cardiol VL - 106 UR - https://doi.org/10.1007/s00392-016-1025-6 DO - 10.1007/s00392-016-1025-6 ID - Cowie2017 ER - TY - JOUR AU - Johnston, S. C. AU - Rootenberg, J. D. AU - Katrak, S. AU - Smith, W. S. AU - Elkins, J. S. PY - 2006 DA - 2006// TI - Effect of a US National Institutes of Health programme of clinical trials on public health and costs JO - Lancet VL - 367 UR - https://doi.org/10.1016/S0140-6736(06)68578-4 DO - 10.1016/S0140-6736(06)68578-4 ID - Johnston2006 ER - TY - JOUR AU - Martin, L. AU - Hutchens, M. AU - Hawkins, C. AU - Radnov, A. PY - 2017 DA - 2017// TI - How much do clinical trials cost? JO - Nat Rev Drug Discov VL - 16 UR - https://doi.org/10.1038/nrd.2017.70 DO - 10.1038/nrd.2017.70 ID - Martin2017 ER - TY - STD TI - Sertkaya A, Birkenbach A, Berlind A, Eyraud J. Examination of clinical trial costs and barriers for drug development: U.S. Department of Health & Human Services; 2014. Contract no. HHSP23320095634WC. https://aspe.hhs.gov/report/examination-clinical-trial-costs-and-barriers-drug-development. Accessed 2 Dec 2019. UR - https://aspe.hhs.gov/report/examination-clinical-trial-costs-and-barriers-drug-development ID - ref26 ER - TY - JOUR AU - Sertkaya, A. AU - Wong, H. H. AU - Jessup, A. AU - Beleche, T. PY - 2016 DA - 2016// TI - Key cost drivers of pharmaceutical clinical trials in the United States JO - Clin Trials VL - 13 UR - https://doi.org/10.1177/1740774515625964 DO - 10.1177/1740774515625964 ID - Sertkaya2016 ER - TY - JOUR AU - Speich, B. AU - Niederhausern, B. AU - Blum, C. A. AU - Keiser, J. AU - Schur, N. AU - Furst, T. PY - 2018 DA - 2018// TI - Retrospective assessment of resource use and costs in two investigator-initiated randomized trials exemplified a comprehensive cost item list JO - J Clin Epidemiol VL - 96 UR - https://doi.org/10.1016/j.jclinepi.2017.12.022 DO - 10.1016/j.jclinepi.2017.12.022 ID - Speich2018 ER - TY - JOUR AU - Speich, B. AU - Niederhausern, B. AU - Schur, N. AU - Hemkens, L. G. AU - Furst, T. AU - Bhatnagar, N. PY - 2018 DA - 2018// TI - Systematic review on costs and resource use of randomized clinical trials shows a lack of transparent and comprehensive data JO - J Clin Epidemiol VL - 96 UR - https://doi.org/10.1016/j.jclinepi.2017.12.018 DO - 10.1016/j.jclinepi.2017.12.018 ID - Speich2018 ER - TY - JOUR AU - Speich, B. AU - Gloy, V. AU - Schur, N. AU - Ewald, H. AU - Hemkens, L. G. AU - Schwenkglenks, M. PY - 2020 DA - 2020// TI - A scoping review shows that several nonvalidated budget planning tools for randomized trials are available JO - J Clin Epidemiol VL - 117 UR - https://doi.org/10.1016/j.jclinepi.2019.09.009 DO - 10.1016/j.jclinepi.2019.09.009 ID - Speich2020 ER - TY - BOOK AU - Swartenbroekx, N. AU - Obyn, C. AU - Guillaume, P. AU - Lona, M. AU - Cleemput, I. PY - 2012 DA - 2012// TI - Manual for cost-based pricing of hospital interventions. Health Technology Assessment (HTA) PB - Belgian Health Care Knowledge Centre (KCE) CY - Brussels ID - Swartenbroekx2012 ER - TY - JOUR AU - Hind, D. AU - Reeves, B. C. AU - Bathers, S. AU - Bray, C. AU - Corkhill, A. AU - Hayward, C. PY - 2017 DA - 2017// TI - Comparative costs and activity from a sample of UK clinical trials units JO - Trials VL - 18 UR - https://doi.org/10.1186/s13063-017-1934-3 DO - 10.1186/s13063-017-1934-3 ID - Hind2017 ER - TY - JOUR AU - Briel, M. AU - Olu, K. K. AU - Elm, E. AU - Kasenda, B. AU - Alturki, R. AU - Agarwal, A. PY - 2016 DA - 2016// TI - A systematic review of discontinued trials suggested that most reasons for recruitment failure were preventable JO - J Clin Epidemiol VL - 80 UR - https://doi.org/10.1016/j.jclinepi.2016.07.016 DO - 10.1016/j.jclinepi.2016.07.016 ID - Briel2016 ER - TY - JOUR AU - Lauer, M. S. AU - D'Agostino, R. B. PY - 2013 DA - 2013// TI - The randomized registry trial—the next disruptive technology in clinical research? JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMp1310102 DO - 10.1056/NEJMp1310102 ID - Lauer2013 ER - TY - JOUR AU - Mathes, T. AU - Buehn, S. AU - Prengel, P. AU - Pieper, D. PY - 2018 DA - 2018// TI - Registry-based randomized controlled trials merged the strength of randomized controlled trials and observational studies and give rise to more pragmatic trials JO - J Clin Epidemiol VL - 93 UR - https://doi.org/10.1016/j.jclinepi.2017.09.017 DO - 10.1016/j.jclinepi.2017.09.017 ID - Mathes2018 ER - TY - JOUR AU - Jolly, S. S. AU - Cairns, J. A. AU - Yusuf, S. AU - Meeks, B. AU - Pogue, J. AU - Rokoss, M. J. PY - 2015 DA - 2015// TI - Randomized trial of primary PCI with or without routine manual thrombectomy JO - N Engl J Med VL - 372 UR - https://doi.org/10.1056/NEJMoa1415098 DO - 10.1056/NEJMoa1415098 ID - Jolly2015 ER - TY - JOUR AU - Lagerqvist, B. AU - Frobert, O. AU - Olivecrona, G. K. AU - Gudnason, T. AU - Maeng, M. AU - Alstrom, P. PY - 2014 DA - 2014// TI - Outcomes 1 year after thrombus aspiration for myocardial infarction JO - N Engl J Med VL - 371 UR - https://doi.org/10.1056/NEJMoa1405707 DO - 10.1056/NEJMoa1405707 ID - Lagerqvist2014 ER - TY - BOOK PY - 2019 DA - 2019// TI - Excess Treatment Costs ID - ref38 ER - TY - JOUR AU - Sheffet, A. J. AU - Flaxman, L. AU - Tom, M. AU - Hughes, S. E. AU - Longbottom, M. E. AU - Howard, V. J. PY - 2014 DA - 2014// TI - Financial management of a large multisite randomized clinical trial JO - Int J Stroke VL - 9 UR - https://doi.org/10.1111/ijs.12259 DO - 10.1111/ijs.12259 ID - Sheffet2014 ER -